McDowell Caryn Gordon 4
4 · Revance Therapeutics, Inc. · Filed Jul 2, 2019
Insider Transaction Report
Form 4
McDowell Caryn Gordon
SVP, GC & Secretary
Transactions
- Other
Common Stock
2019-06-28$11.02/sh+1,000$11,025→ 23,935 total
Footnotes (1)
- [F1]These shares were acquired by Ms. McDowell under the Issuer's 2014 Employee Stock Purchase Plan (the "Plan") on June 28, 2019 in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). Ms. McDowell purchased the maximum number of shares allowable under the Issuer's Plan for the period ended June 30, 2019.